SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000880771-14-000008
Filing Date
2014-08-11
Accepted
2014-08-11 17:02:41
Documents
11
Period of Report
2014-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q scln-20140630x10q.htm 10-Q 1739207
2 EX-31.1 scln-20140630ex311efd98a.htm EX-31.1 18621
3 EX-31.2 scln-20140630ex312a0d9fa.htm EX-31.2 18635
4 EX-32.1 scln-20140630ex321ccced9.htm EX-32.1 12832
5 EX-32.2 scln-20140630ex322a46acc.htm EX-32.2 12701
  Complete submission text file 0000880771-14-000008.txt   7737320

Data Files

Seq Description Document Type Size
6 EX-101.INS scln-20140630.xml EX-101.INS 1317018
7 EX-101.SCH scln-20140630.xsd EX-101.SCH 34656
8 EX-101.CAL scln-20140630_cal.xml EX-101.CAL 44396
9 EX-101.DEF scln-20140630_def.xml EX-101.DEF 84639
10 EX-101.LAB scln-20140630_lab.xml EX-101.LAB 238964
11 EX-101.PRE scln-20140630_pre.xml EX-101.PRE 213233
Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125
Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456
SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)

IRS No.: 943116852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19825 | Film No.: 141031360
SIC: 2834 Pharmaceutical Preparations